aspirin

Generic: aspirin

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8256
Product ID 68788-8256_e4df6c96-5b64-4ad8-ab2d-7f1d5f155b91
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number 343
Listing Expiration 2027-12-31
Marketing Start 2022-09-16

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888256
Hyphenated Format 68788-8256

Supplemental Identifiers

UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number 343 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68788-8256-1)
  • 20 TABLET in 1 BOTTLE (68788-8256-2)
source: ndc

Packages (2)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e4df6c96-5b64-4ad8-ab2d-7f1d5f155b91", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "spl_set_id": ["b0e260a2-4e86-479a-b17b-60324694f669"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8256-1)", "package_ndc": "68788-8256-1", "marketing_start_date": "20220916"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8256-2)", "package_ndc": "68788-8256-2", "marketing_start_date": "20220916"}], "brand_name": "Aspirin", "product_id": "68788-8256_e4df6c96-5b64-4ad8-ab2d-7f1d5f155b91", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "68788-8256", "generic_name": "Aspirin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "343", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20220916", "listing_expiration_date": "20271231"}